Upstream Bioprocessing Monitoring

About Nirrin Technologies

Nirrin Technologies is a private, early-revenue stage company founded in 2017, headquartered in San Diego with operations in Billerica, MA. It has developed the Atlas™, a process analytical technology (PAT) system that uses a novel NIR-based spectroscopy platform (HPTLS) to monitor critical quality attributes like antibody titer and excipient concentration in biomanufacturing. The company claims its solution is significantly faster, cheaper, and requires less sample volume than incumbent techniques, targeting analytical blind spots in upstream and downstream processing. Nirrin operates in the Diagnostics and Digital Health sectors, serving the biopharmaceutical manufacturing market.